Boston, MA, US
Small Business (1-10M TTM Revenue)
We collaborate with the world’s leading pharma, biotech and academic organisations to lower the risks and time frames in disease research and preclinical drug discovery
Euretos provides a unique combination of predictive computational disease models and direct access to our AI-integrated knowledge base of biomolecular databases, literature and patents to evaluate predictions and findings. This empowers scientists to draw their own, evidence based, conclusions and develop data-driven insights into human disease biology.
Our ready-to-use applications and capabilities enable taking a data-driven approach to:
Target Discovery – Novel target predictions to improve preclinical pipeline performance in all therapeutic areas
Indication Selection – Novel disease association predictions to expand indications of existing drugs
Target Evaluation – Accelerate assessment of target candidates from in-house discovery and in-licensing
|Euretos Services - Europe Yalelaan 1 Utrecht, Utrecht, 3584 CL Netherlands|
|Euretos Services - United States One Beacon Street, 15th Floor Boston, MA, 02108 United States|
To request access, simply fill out the form below and we will contact you.